Earlier quoted context omitted.
> Unfortunately they cannot consent to conditions like "Don't burden the hospital system if you take the wrong dosage". By this logic the FDA would have to ban Tylenol and Robitussin. Tens of thousands of ER visits every year. The government should generally be concerned with preventing deception and coercion and pricing externalities, because otherwise people have the incentive to do them and they would be prolific.…
> By this logic the FDA would have to ban Tylenol and Robitussin. Tens of thousands of ER visits every year. It's almost like there's a balance of harms to be evaluated. I'd bet the cheap availability of paracetamol etc. saves more hospital visits than it causes, but I don't have the data to hand.
Yes, and I don't trust that the government can generate a one size fits all model that universally reduces harm. They're just not capable of it, and yet they comfortably assert their authority as if they are, and so they act without actually taking any measure of the impact of their own actions.
It's the problem with any agency. Sometimes the best answer is actually "do nothing" or most likely "regulate elsewhere through different authority."
So, I don't think the FDA paying an oversized amount of attention to one retail segment is going to do anything meaningful in the long term and we shouldn't have to pay for their amateur expeditionary efforts here, both in terms of funding the agency, and in allowing them to control markets on their own without any request or complaint process driving their actions.